| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.3 | 2e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |